RAPT THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)

Item 5.07 Submission of Matters to a Vote of Security Holders.

On May 25, 2022, RAPT Therapeutics, Inc. (the "Company") held its 2022 annual meeting of stockholders (the "Annual Meeting"). The following is a brief description of each matter voted upon at the Annual Meeting, as well as the number of votes cast for and against each matter, and if applicable, the number of abstentions and broker non-votes with respect to each matter. A more complete description of each matter is described in more detail in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 11, 2022.

1. Election of Directors



                                      Votes      Broker
Director Name          Votes For    Withheld    Non-Votes
Michael Giordano, MD   22,848,997   1,545,121   1,787,483
Wendye Robbins, MD     22,920,508   1,473,610   1,787,483

The Class III director nominees were elected to hold office until the Company's 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified.

2. Ratification of Selection of Independent Registered Public Accounting Firm

                                  Votes
Firm                Votes For    Against   Abstentions

Ernst & Young LLP 26,178,293 1,370 1,938

The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2022.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses